(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTO, E, MÉTODOS PARA TRATAR UM DISTÚRBIO ASSOCIADO COM PROLIFERAÇÃO CELULAR ANORMAL E PARA REDUZIR O EFEITO DE QUIMIOTERAPIA EM CÉLULAS SAUDÁVEIS.

ArquivadaInvention PatentPCT · US2017040093

Application data

Number

112018077136

Type

Invention Patent

Filing

06/29/2017

Publication

04/30/2019

PCT

US2017040093

Progress at the INPI

  1. Filing06/29/17
  2. Publication04/30/19
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/26/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

G1 THERAPEUTICS, INC.

US

Inventors

D. J. (pessoa física)

US

J. S. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/357630 · 07/01/2016

Abstract

Essa invenção está na área de compostos à base de pirimidina para o tratamento de distúrbios envolvendo proliferação celular anormal, incluindo, mas não limitado a, tumores e cânceres.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

04/26/2022

RPI 2677

Parecer de pré-exame

#6.23

01/18/2022

RPI 2663

Notificação de entrada na fase nacional - PCT

#1.3

04/30/2019

RPI 2521

Alteração de dados cadastrais

#1.1

04/16/2019

RPI 2519

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.